Jordi Remon

Jordi Remon

UNVERIFIED PROFILE

Are you Jordi Remon?   Register this Author

Register author
Jordi Remon

Jordi Remon

Publications by authors named "Jordi Remon"

Are you Jordi Remon?   Register this Author

40Publications

685Reads

-Profile Views

Immune-Related Adverse Events and Outcomes in Patients with Advanced Non-Small Cell Lung Cancer: A Predictive Marker of Efficacy?

J Thorac Oncol 2019 Jun 23;14(6):963-967. Epub 2019 Apr 23.

Gustave Roussy, Cancer Medicine Department, Villejuif, France; University Paris-Sud, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.02.031DOI Listing
June 2019

Advanced Stage Non-Small Cell Lung Cancer: Advances in Thoracic Oncology 2018.

J Thorac Oncol 2019 Apr 16. Epub 2019 Apr 16.

Guangdong Lung Cancer Institute; Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences; Guangzhou; China.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864193028
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2019.03.022DOI Listing
April 2019

Could WNT inhibitors really knock on the treatment door of small cell lung cancer?

J Thorac Dis 2019 Mar;11(Suppl 3):S381-S384

Medical Oncology Department, Centro Integral Oncología Clara Campal Barcelona, HM-Delfos, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2018.12.46DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424724PMC
March 2019

Precision oncology: separating the wheat from the chaff.

ESMO Open 2018 30;3(6):e000446. Epub 2018 Oct 30.

Hospital Vall d'Hebrón, Oncology Data Science (ODysSey) Group, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://esmoopen.bmj.com/lookup/doi/10.1136/esmoopen-2018-000
Publisher Site
http://dx.doi.org/10.1136/esmoopen-2018-000446DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212683PMC
October 2018

Future Genetic/Genomic Biomarker Testing in Non-Small Cell Lung Cancer.

Am Soc Clin Oncol Educ Book 2017;37:12-17

From the Department of Oncology Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Department of Oncology Medicine, Hospital de la Vall d'Hebron, Barcelona, Spain; Institut National du Cancer, Boulogne-Billancourt, France; University Paris-Sud and Gustave Roussy Cancer Campus, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EDBK_100007DOI Listing
September 2018

Prognostic value of HLA-A2 status in advanced non-small cell lung cancer patients.

Lung Cancer 2017 10 29;112:10-15. Epub 2017 Jul 29.

Medical Oncology Department, Gustave Roussy, Villejuif, France; University Paris-Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.07.004DOI Listing
October 2017

LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value.

Lung Cancer 2017 10 7;112:62-68. Epub 2017 Aug 7.

Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France; University Paris-Sud Kremlin Bicetre/Chatenay-Malabry, Le Kremlin-Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.08.002DOI Listing
October 2017

Peritoneal recurrence of thymoma treated by surgery and hyperthermic intraperitoneal chemotherapy.

Lung Cancer 2017 09 8;111:59-60. Epub 2017 Jul 8.

Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Villejuif, France; Paris-Sud University, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.06.011DOI Listing
September 2017

Symptomatic leptomeningeal metastasis improvement with nivolumab in advanced non-small cell lung cancer patient.

Lung Cancer 2017 06 27;108:72-74. Epub 2017 Feb 27.

Department of Cancer Medicine, Gustave Roussy, Villejuif, France; University Paris-Sud, Orsay, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.02.022DOI Listing
June 2017

Immune checkpoint inhibitors in first-line therapy of advanced non-small cell lung cancer.

Curr Opin Oncol 2017 03;29(2):97-104

aGustave Roussy, Cancer Medicine Department, Villejuif bParis Sud University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000351DOI Listing
March 2017

Brain Radionecrosis Treated with Bevacizumab in a Patient with Resected Squamous Cell Carcinoma of the Lung.

J Thorac Oncol 2017 01 17;12(1):e1-e3. Epub 2016 Aug 17.

Gustave Roussy, Paris-Saclay University, Medical Oncology Department, Villejuif, France; Paris-Sud University and Gustave Roussy Cancer Campus, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.08.124DOI Listing
January 2017

Erratum to "Sunitinib in patients with advanced thymic malignancies: cohort from the French RYTHMIC network" [Lung Cancer, 97 (July 2016), 99-104].

Lung Cancer 2016 11 6;101:146. Epub 2016 Oct 6.

Gustave Roussy Cancer Campus, Villejuif, France; University Paris-Sud and Gustave Roussy Cancer Campus, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.09.014DOI Listing
November 2016

Unravelling signal escape through maintained EGFR activation in advanced non-small cell lung cancer (NSCLC): new treatment options.

ESMO Open 2016 1;1(4):e000081. Epub 2016 Aug 1.

Medical Oncology Department, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Paris Sud University, Orsay, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2016-000081DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070255PMC
August 2016

Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network.

Lung Cancer 2016 07 3;97:99-104. Epub 2016 May 3.

Gustave Roussy Cancer Campus, Villejuif, France; University Paris-Sud and Gustave Roussy Cancer Campus, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.04.024DOI Listing
July 2016

The 5000% case: a glimpse into the financial issue of lung cancer treatment.

Eur Respir J 2016 05;47(5):1331-3

Medical Oncology Dept, Institute Gustave Roussy, Villejuif, France Université Paris-Sud and Institute Gustave Roussy Cancer Campus, Villejuif, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00548-2016DOI Listing
May 2016

Predictive biomarkers for programmed death-1/programmed death ligand immune checkpoint inhibitors in nonsmall cell lung cancer.

Curr Opin Oncol 2016 Mar;28(2):122-9

aMedical Oncology DepartmentbLaboratoire d'immunomonitoring en Oncologie UMS 3655 CNRS/US 23 INSERM, Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000263DOI Listing
March 2016

Common EGFR-mutated subgroups (Del19/L858R) in advanced non-small-cell lung cancer: chasing better outcomes with tyrosine kinase inhibitors.

Future Oncol 2015 28;11(8):1245-57. Epub 2015 Jan 28.

Medical Oncology Department, Hospital Clínic, Villarroel 170, 08036 Barcelona, Spain.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/fon.15.15
Publisher Site
http://dx.doi.org/10.2217/fon.15.15DOI Listing
February 2016

Circulating free DNA, new dynamic marker in nonsmall cell lung cancer patients?

Eur Respir J 2015 Dec;46(6):1548-50

Oncologic Intensive Care and Emergencies and Thoracic Oncology Dept, Institut Jules Bordet (ULB), Brussels, Belgium.

View Article

Download full-text PDF

Source
http://erj.ersjournals.com/content/erj/46/6/1548.full.pdf
Web Search
http://erj.ersjournals.com/lookup/doi/10.1183/13993003.01482
Publisher Site
http://dx.doi.org/10.1183/13993003.01482-2015DOI Listing
December 2015

AZD9291 in EGFR-mutant advanced non-small-cell lung cancer patients.

Future Oncol 2015 Nov 9;11(22):3069-81. Epub 2015 Oct 9.

Gustave Roussy, Medical Oncology Department, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.15.250DOI Listing
November 2015

Crizotinib Improves Osteoarthritis Symptoms in a ROS1-Fusion Advanced Non-Small Cell Lung Cancer Patient.

J Thorac Oncol 2015 Aug;10(8):e72-3

*Thoracic Oncology Section, Gustave Roussy Cancer Campus, Villejuif, France; and †Thoracic Oncology Section, University of Paris-Sud, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000561DOI Listing
August 2015

The epidermal growth factor receptor (EGRF) in lung cancer.

Transl Respir Med 2015 24;3. Epub 2015 Feb 24.

Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Universitat Autónoma de Barcelona, Department of Medicine, Badalona, Barcelona Spain ; Cancer Biology & Precision Medicine Program, Catalan Institute of Oncology, Germans Trias i Pujol Health Sciences Institute and Hospital, Campus Can Ruti, Badalona, Barcelona Spain ; Fundación Molecular Oncology Research, Sabino Arana 5-19, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40247-015-0013-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366432PMC
March 2015

Assessment of ALK status by FISH on 1000 Spanish non-small cell lung cancer patients.

J Thorac Oncol 2014 Dec;9(12):1816-20

*Servei d'Oncologia Mèdica, Hospital del Mar, Barcelona, Spain; †Laboratori de Citogenètica Molecular, Department de Patologia, Hospital del Mar, Barcelona, Spain; ‡Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; §Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain; ‖Department de Patologia, Hospital del Mar, Barcelona, Spain; ¶Medical Oncology Department, Hospital de Mataró, Barcelona, Spain; #Medical Oncology Service, iCMHO, Hospital Clinic Barcelona, Barcelona, Spain; **Pathology Department, Hospital Lluís Alcanyís, Xàtiva, Spain; ††Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; ‡‡Medical Oncology Department, Institut Català d'Oncologia (ICO), Hospital Universitari Dr. Josep Trueta, Girona, Spain; §§Department of Medical Sciences, University of Girona, Spain; ‖‖Pathology Department, Complejo Asistencial de Leon, Castilla y Leon, Spain; and ¶¶Medical Oncology Department, Institut Català d'Oncologia (ICO), Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/jto/2014/12000/Assessment_of_AL
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000361DOI Listing
December 2014

Adjuvant treatment in resected non-small cell lung cancer: current and future issues.

Crit Rev Oncol Hematol 2013 Nov 1;88(2):375-86. Epub 2013 Jul 1.

Medical Oncology Department, Hospital de Mataró, Carretera de la Cirera, s/n, 08304 Mataró, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2013.05.017DOI Listing
November 2013

Malignant mesothelioma: new insights into a rare disease.

Cancer Treat Rev 2013 Oct 28;39(6):584-91. Epub 2012 Dec 28.

Medical Oncology Department, Hospital de Mataró, Carretera de la Cirera, s/n, 08304 Mataró, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2012.12.005DOI Listing
October 2013

Brain metastases from renal cell carcinoma. Should we change the current standard?

Cancer Treat Rev 2012 Jun 20;38(4):249-57. Epub 2011 Jul 20.

Medical Oncology Department, Hospital de Mataró, Carretera de la Cirera, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2011.06.008DOI Listing
June 2012

SEOM guidelines for the treatment of malignant pleural mesothelioma.

Clin Transl Oncol 2011 Aug;13(8):569-73

Servicio de Oncología Médica, Hospital de Mataró, Mataró, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12094-011-0699-5DOI Listing
August 2011